Publication | Closed Access

A synthetic diosgenin primary amine derivative attenuates LPS-stimulated inflammation via inhibition of NF-κB and JNK MAPK signaling in microglial BV2 cells

InflammationNeuroinflammationAnti-inflammatoryMedicineImmunologyJnk MapkBrain-immune InteractionImmune FunctionNeuroimmunologyMicroglial Bv2 CellsPharmacologyCell BiologyCell SignalingMolecular Signaling